The effect of dexmedetomidine on haemodynamics during intracranial procedures: a meta-analysis

References

• Zhao J, Zhou C. The protective and hemodynamic effects of dexmedetomidine on hypertensive cerebral hemorrhage patients in the perioperative period. Exp Ther Med. 2016;12(5):2903–08. doi:10.3892/etm.2016.3711.
   PubMed Web of Science ®Google Scholar
• Choi IY, Hwang L, Jin JJ, Ko IG, Kim SE, Shin MS, Shin KM, Kim CJ, Park SW, Han JH, et al. Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils. Exp Ther Med. 2017;13(1):107–16. doi:10.3892/etm.2016.3956.
   PubMed Web of Science ®Google Scholar
• F, Fu H, Sun K, Wu SDong T. Effect of dexmedetomidine on cerebral ischemia-reperfusion rats by activating mitochondrial atp-sensitive potassium channel. Metab Brain Dis. 2017;32(2):539-546.
   PubMed Web of Science ®Google Scholar
• Bekker A, Sturaitis M, Bloom M, Moric M, Golfinos J, Parker E, Babu R, Pitti A. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 2008;107(4):1340–47. doi:10.1213/ane.0b013e3181804298.
   PubMedGoogle Scholar
• Soliman RN, Hassan AR, Rashwan AM, Omar AM. Prospective, randomized study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anaesthesia. Middle East J Anaesthesiol. 2011;21(3):325–34.
   PubMedGoogle Scholar
• Kaushal RP, Deepesh G, Brajesh K, Ashish M. Study to assess the role of dexmedetomidine in patients with intracranial tumors undergoing craniotomy under general anesthesia. J Evol Med Dental Sci. 2013;2(43):8313.
   Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J NATL Cancer I. 1959;22(4):719–48.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
   PubMedGoogle Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–26.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
   PubMed Web of Science ®Google Scholar
• Tanskanen PE, Kytta JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery. A double-blind, randomized and placebo-controlled study. Brit J Anaesth. 2006;97(5):658–65. doi:10.1093/bja/ael220.
   PubMed Web of Science ®Google Scholar
• Uyar AS, Yagmurdur H, Fidan Y, Topkaya C, Basar H. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesth. 2008;20(3):174–79. doi:10.1097/ANA.0b013e318177e5eb.
   PubMed Web of Science ®Google Scholar
• Gu XH, Wang YC. Effects of dexmedetomidine on responses during the recovery from general anesthesia in clipping of intracranial aneurysm. Chin J New Drugs. 2012;21(9):1010–12. 1015.
   Google Scholar
• Huang GH, Yang YH, Wang B. Effects of dexmedetomidine on hemodynamics during extubation of patients with intracranial. Jilin Medical. 2013;34(18):3552–53.
   Google Scholar
• Meng FF, Wei L, Xuan F, Liu Y. The application of dexmedetomidine in patients with intracranial tumors undergoing cranitomy under general anesthesia. J Clin Anesthesiol. 2014;30(11):1104–06.
   Google Scholar
• Chen XM, Chen GF. Effect of dexmedetomidine on hemodynamics and neuroprotection in patients undergoing brain tumor surgery. J Clin Anesthesiol. 2015;31(1):15–17.
   Google Scholar
• Seo H, Ryu HG, Son JD, Kim JS, Ha EJ, Kim JE, Park HP. Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease. A retrospective observational study. Medicine. 2016;95(52):e5712. doi:10.1097/MD.0000000000004864.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gonzalez R, Sobrino T, Veiga S, Lopez P, Rodriguez-Garcia J, Del Rio SV, Baluja A, Castillo J, Alvarez J. Neuroprotective effects of dexmedetomidine conditioning strategies. Evidences from an in vitro model of cerebral ischemia. Life Sci. 2016;144:162–69. doi:10.1016/j.lfs.2015.12.007.
   PubMed Web of Science ®Google Scholar
• Akpinar H, Naziroglu M, Ovey IS, Cig B, Akpinar O. The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats. Contribution of TRPM2 and TRPV1 channels. Sci Rep-UK. 2016;6:37196. doi:10.1038/srep37196.
   PubMed Web of Science ®Google Scholar
• Arulvelan A, Manikandan S, Easwer HV, Krishnakumar K. Effect of loading dose of dexmedetomidine on dynamic cerebral blood flow autoregulation in patients with intracranial glial neoplasms. J Neurosurg Anesth. 2015;27(4):289–94. doi:10.1097/ANA.0000000000000159.
   PubMed Web of Science ®Google Scholar
• Wang Z, Kou D, Li Z, He Y, Yu W, Du H. Effects of propofol-dexmedetomidine combination on ischemia reperfusion-induced cerebral injury. NeuroRehabilitation. 2014;35(4):825–34. doi:10.3233/NRE-141177.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Sessler DI. The potential role of alpha(2) agonists for noncardiac surgery. Anesthesiology. 2012;116(6):1192–94. doi:10.1097/ALN.0b013e3182567fab.
   PubMed Web of Science ®Google Scholar
• Olsen KS, Pedersen CB, Madsen JB, Ravn LI, Schifter S. Vasoactive modulators during and after craniotomy. Relation to postoperative hypertension. J Neurosurg Anesth. 2002;14(3):171–79. doi:10.1097/00008506-200207000-00001.
   PubMed Web of Science ®Google Scholar
• Yoo H, Iirola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, Olkkola KT, Jusko WJ. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects. Eur J Clin Pharmacol. 2015;71(10):1197–207. doi:10.1007/s00228-015-1913-0.
   PubMed Web of Science ®Google Scholar
• Kose EA, Bakar B, Kasimcan O, Atilla P, Kilinc K, Muftuoglu S, Apan A. Effects of intracisternal dexmedetomidine on cerebral neuronal cells in rat. A preliminary study. Turk Neurosurg. 2013;23(1):38–44. doi:10.5137/1019-5149.JTN.6261-12.2.
   PubMed Web of Science ®Google Scholar